Several studies have identified early and significant neuropathological changes in the hypothalamus of AD patients, including an accumulation of amyloid and tau, atrophy, reduced glucose metabolism, and trends of hypoperfusion [3, 24–28]. The gene discussed is MAPT; the disease is Alzheimer disease.